| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRCL |
Stericycle Inc |
Director |
– • – |
2008-11-19 |
4 |
D |
$59.24 |
$1,383,669 |
D/D |
(23,357) |
2,850,589 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-12-19 |
5 |
GD |
$0.00 |
$0 |
D/D |
11,218 |
2,668,731 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-12-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
185 |
2,668,546 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-12-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
962 |
2,667,584 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-12-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
296 |
2,667,288 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2009-03-13 |
4 |
S |
$48.56 |
$7,818,337 |
D/D |
(161,000) |
2,689,589 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2009-03-16 |
4 |
S |
$48.08 |
$2,594,931 |
D/D |
(53,971) |
2,635,618 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-03-16 |
4 |
A |
$7.97 |
$1,593,700 |
I/I |
200,000 |
155,933 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-03-17 |
4 |
A |
$7.71 |
$771,360 |
I/I |
100,000 |
189,267 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2009-03-17 |
4 |
S |
$48.40 |
$4,839,670 |
D/D |
(100,000) |
2,535,618 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-27 |
4 |
B |
$12.35 |
$564,262 |
I/I |
45,700 |
204,501 |
2.1 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-28 |
4 |
B |
$12.14 |
$259,082 |
I/I |
21,334 |
225,835 |
2.1 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-28 |
4 |
B |
$12.14 |
$518,140 |
I/I |
42,666 |
225,833 |
2.1 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-29 |
4 |
B |
$11.98 |
$75,972 |
I/I |
6,343 |
227,923 |
2.1 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-10-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
798,767 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-10-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,886,590 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-02 |
4 |
B |
$9.48 |
$40,764 |
D/D |
4,300 |
2,890,890 |
2.37 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-04 |
4 |
B |
$9.04 |
$1,808,260 |
D/D |
200,000 |
3,090,890 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-05 |
4 |
B |
$4.50 |
$525,000 |
D/D |
110,000 |
3,200,890 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-06 |
4 |
B |
$3.90 |
$610,100 |
D/D |
154,000 |
3,354,890 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-09 |
4 |
B |
$3.60 |
$626,615 |
D/D |
151,782 |
3,506,672 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-13 |
4 |
B |
$10.00 |
$250,000 |
D/D |
25,000 |
3,531,672 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-04 |
4 |
B |
$3.66 |
$146,260 |
D/D |
40,000 |
3,571,672 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-05 |
4 |
B |
$3.71 |
$122,791 |
D/D |
33,100 |
3,604,772 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-08 |
4 |
B |
$3.80 |
$60,754 |
D/D |
16,000 |
3,620,772 |
2.45 |
- |
|
634 Records found
|
|
Page 3 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
